We are live on
!
Find out more
ACM
Ativo Capital Management Portfolio holdings
AUM
$115M
1-Year Est. Return
19.02%
This Fund
S&P 500
This Quarter
Est. Return
+5.88%
1 Year Est. Return
+19.02%
3 Year Est. Return
+57.9%
5 Year Est. Return
+80.23%
10 Year Est. Return
+380.01%
AUM
$114M
AUM Growth
+$17.7M
(+18%)
Cap. Flow
+$10.4M
Cap. Flow
% of AUM
9.05%
Top 10 Holdings %
Top 10 Hldgs %
51.42%
Holding
54
New
5
Increased
5
Reduced
38
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin FTSE India ETF
FLIN
|
+$16.9M |
| 2 |
AXA
AXA ADS (1 ORD SHS)
AXA
|
+$776K |
| 3 |
Vipshop
VIPS
|
+$279K |
| 4 |
Alibaba
BABA
|
+$179K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dr. Reddy's Laboratories
RDY
|
+$5.61M |
| 2 |
TSMC
TSM
|
+$1.72M |
| 3 |
Stellantis
STLA
|
+$1.39M |
| 4 |
AerCap
AER
|
+$938K |
| 5 |
Check Point Software Technologies
CHKP
|
+$865K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Healthcare | 10.12% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 8.65% |
| 5 | Industrials | 4.47% |
Similar funds
PCM
CF
ACM
PHWM
MCI
DF
PPWM
RA
Ativo Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Ativo Capital Management held 54 positions worth $114M, up 18% from $96.6M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Ativo Capital Management deployed $10.4M of net new capital in Q3 2024, opening 5 new positions and adding to 5 existing holdings. Its largest new stake was Franklin FTSE India ETF: 414,720 shares worth $17.4M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was TSMC, an estimated $1.72M trimmed.
- Ativo Capital Management's largest Q3 2024 buy was Franklin FTSE India ETF: 414,720 shares worth $17.4M.
- Ativo Capital Management added most to AXA ADS (1 ORD SHS) in Q3 2024, an estimated $776K increase.
- Ativo Capital Management's biggest Q3 2024 reduction was TSMC, cutting an estimated $1.72M.
- Ativo Capital Management fully exited Dr. Reddy's Laboratories in Q3 2024, selling an estimated $5.61M.
- Ativo Capital Management's ten largest holdings make up 51% of its $114M portfolio in Q3 2024.
- Ativo Capital Management opened 5 new positions and closed 4 in Q3 2024.
- Ativo Capital Management's portfolio value rose 18% quarter-over-quarter to $114M.
Based on Ativo Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.